Science


Posts filtered by tags: Catherine Schuster Bruce[x]


 

The CDC delayed its looser rules for vaccinated people, while states ease restrictions despite being told it's too soon

Director of the Centers for Disease Control Rochelle Walensky speaking at a White House press briefing on March 1, 2021. White House/YouTube The CDC delayed issuing new, laxer COVID-19 rules for vaccinated people, Politico reported. The guidance was due to be updated Thursday, but was slowed without a clear reason. It came after President Biden criticized states like Texas and Mississippi for relaxing their COVID-19 rules.  Visit the Business section of Insider for more stories. The US Cen...
Tags: Politics, Texas, Science, Mississippi, Cdc, White House, Politico, US, San Francisco, Trends, Joe Biden, Chicago, News UK, Michigan, Biden, Anthony Fauci


How AstraZeneca's vaccine got mired in politics and mistrust to become Europe's least favorite shot

A vial and syringe are seen in front of the AstraZeneca logo. Reuters/Dado Ruvic Europeans are turning down the AstraZeneca vaccine, threatening the EU's path out of the pandemic. The problem flared last week, but has been months in the making. AstraZeneca and EU leaders both made mistakes that sapped public confidence. Experts and regulators say the shot is safe, and EU leaders are moving to repair the damage. Visit the Business section of Insider for more stories. "There is currently an ...
Tags: Europe, Politics, UK, Science, France, Scotland, Germany, Angela Merkel, Berlin, Israel, US, Trends, Eu, Ireland, South Africa, Oxford


People who've had COVID-19 might only need one vaccine jab - and saving shots on them could free up millions of doses for others

Justin Tallis - Pool / Getty Images Some experts believe people who have had COVID-19 should get just one shot of two-dose coronavirus vaccines. This would give these people protection while freeing up vaccine doses for others, they say. However, other experts warn the approach could be logistically difficult and scientifically "risky."  Visit the Business section of Insider for more stories. Experts are divided on whether people who have already had COVID-19 need a full coronavirus vacci...
Tags: UK, Science, London, Nbc, Maryland, France, US, Trends, Joe Biden, Analysis, Healthcare, Astrazeneca, Pfizer, Vaccine, Oxford University, Vaccines


The US accused China of forcing American diplomats to take anal swab tests for COVID-19

A medical worker taking a throat swab for a COVID-19 test in Beijing. NICOLAS ASFOURI/AFP via Getty Images The State Department accused China of making US diplomats take anal COVID-19 tests, Vice reported. A spokesperson told Vice that China said the tests were done "in error" after the US complained. China said it didn't require diplomats to take the tests but also didn't deny the tests happened. Visit the Business section of Insider for more stories. The US has accused China of making Am...
Tags: Politics, Science, China, US, Trends, News UK, State Department, The Washington Post, Afp, Ministry Of Foreign Affairs, Chinese Foreign Ministry, Zhao, Global Times, Coronavirus, COVID-19, Zhao Lijian


The US accused China of forcing its diplomats to take anal swab tests for COVID-19

A medical worker takes a throat swab for a COVID-19 test in Beijing, China. NICOLAS ASFOURI/AFP via Getty Images The State Department accused China of making its diplomats take anal COVID-19 tests, Vice reported. A spokesperson told Vice that China said the tests were done "in error" after the US complained. China said it doesn't require diplomats to take the tests, but didn't deny that it happened. Visit the Business section of Insider for more stories. The US has accused China of making ...
Tags: Politics, Science, China, US, Trends, News UK, State Department, The Washington Post, Pcr, Afp, Ministry Of Foreign Affairs, Zhao, Global Times, Coronavirus, COVID-19, Zhao Lijian


Pfizer's COVID-19 vaccine performs just as well in the real world as it did in trials, a landmark Israeli study of more than 1 million people suggests. It was 94% effective.

Rabbi Yisrael Meir Lau receives a COVID-19 coronavirus vaccine at the Ichilov Hospital in Tel Aviv, Israel, Sunday, December 20, 2020. Ariel Schalit/AP Photo Pfizer-BioNTech's two-dose coronavirus vaccine was 94% effective at protecting against COVID-19 in a real-world study. In late-stage clinical trials before it was authorized, it was 95% effective. The new Israeli study of the Pfizer vaccine involved more than 1 million people. Visit the Business section of Insider for more stories. P...
Tags: Health, UK, Science, Israel, US, Trends, Harvard University, Healthcare, Sydney, Pfizer, Centers For Disease Control And Prevention, University of New South Wales, New England Journal of Medicine, Tel Aviv Israel, Johns Hopkins University, Ben Gurion University of the Negev


A coronavirus variant identified in California seems more infectious and deadly, a study found, with cases thought to be doubling every 18 days - but the scale of the threat is unclear

Pam Rasmussen, a principal, taking the temperature of arriving students during summer-school sessions in Monterey Park, California, on July 9. FREDERIC J. BROWN/AFP via Getty Images A study suggests a coronavirus variant first found in California is more contagious and deadly. The early study, first reported by Science, hasn't been formally scrutinized in a peer review. Some experts say more data is needed before the strain is considered especially dangerous. Visit the Business section of ...
Tags: Health, UK, Science, California, Boston, US, Trends, Taiwan, South Africa, New York Times, Healthcare, The New York Times, University Of California, Madison, Los Angeles Times, University Of Wisconsin


A coronavirus variant identified in California is more infectious, more deadly, and cases are doubling every 18 days, a study suggests - but the scale of the threat is unclear

Principal Pam Rasmussen (L) takes the temperature of arriving students as per coronavirus guidelines during summer school sessions in Monterey Park, California on July 9, 2020. FREDERIC J. BROWN/AFP via Getty Images A coronavirus variant first found in California is more contagious and deadlier than the original strain, an early study suggests. The study, first reported by Science, hasn't been formally scrutinized by other experts in a peer review. Some experts say more data is needed befo...
Tags: Health, UK, Science, California, Boston, US, Trends, Taiwan, South Africa, New York Times, Healthcare, The New York Times, UCSF, University of Wisconsin Madison, LA Times, Harvard T H Chan School of Public Health


A single shot of Pfizer and BioNTech's COVID-19 vaccine reduces the risk of infection by 70%, the first real-world data suggests

Medical assistant April Massaro gives a first dose of Pfizer BioNTech's COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California. Irfan Khan / Los Angeles Times via Getty Images One shot of Pfizer and BioNTech's vaccine reduced the risk of coronavirus infection by 70% in a UK study. The COVID-19 vaccine's protection increased to 85% in those who got two shots. The data showed Pfizer's vaccine worked against a mutated va...
Tags: Health, UK, Science, Cdc, Scotland, Israel, US, Trends, Healthcare, Pfizer, Vaccine, Phe, Pcr, Lancet, Centers for Disease Control and Prevention CDC, Massaro


A single shot of Pfizer and BioNTech's COVID-19 vaccine reduces the risk of infection by 70%, the first real-world UK data suggests

Medical assistant April Massaro gives a first dose of Pfizer BioNTech's COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California. Irfan Khan / Los Angeles Times via Getty Images One shot of Pfizer and BioNTech's vaccine reduced the risk of coronavirus infection by 70% in a UK study. The COVID-19 vaccine's protection increased to 85% in those who got two shots. The data showed Pfizer's vaccine worked against a mutated va...
Tags: Health, UK, Science, Cdc, Scotland, Israel, US, Trends, Healthcare, Pfizer, Vaccine, Phe, Pcr, Lancet, Centers for Disease Control and Prevention CDC, Massaro


The coronavirus variant found in South Africa has been detected in a New York resident for the first time. 10 states have reported cases so far.

New York Gov. Andrew Cuomo. Lev Radin/Pacific Press/LightRocket via Getty The coronavirus variant first found in South Africa has been detected in a New York resident, Gov. Cuomo said Sunday. The variant, called B.1.351, has spread to 36 countries, and 10 states in the US. The variant from South Africa may be able to evade vaccines, studies suggest. Visit the Business section of Insider for more stories. The coronavirus variant found in South Africa has been confirmed in a New York residen...
Tags: Health, New York, Texas, Science, California, Cdc, New York City, US, Trends, South Africa, Connecticut, Healthcare, Astrazeneca, Novartis, Pfizer, Nassau County


Pfizer-BioNTech's COVID-19 vaccine produces a much weaker immune response against the variant found in South Africa, a new study suggests

Margaret Keenan, 90, the first patient in the United Kingdom to receive the Pfizer/BioNtech covid-19 vaccine, speaks with Healthcare assistant Lorraine Hill as she prepares to leave University Hospital Coventry & Warwickshire, the day after receiving the first of two doses of the vaccine, on December 9, 2020 in Coventry, United Kingdom. The UK is the first country in the world to start vaccinating people with the Pfizer/BioNTech jab. Jonny Weeks/The Guardian - Pool/Getty Images Pfizer-BioN...
Tags: Health, UK, Science, Israel, US, Trends, South Africa, United Kingdom, Healthcare, Astrazeneca, Novartis, Pfizer, Vaccine, Reuters, Johnson Johnson, Shi


A world-first 'human challenge' trial will infect healthy young people with coronavirus to study how it spreads and which vaccines work best

A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against the novel coronavirus, at Baragwanath Hospital in Soweto, South Africa, June 24, 2020. Siphiwe Sibeko/Reuters A world-first study in the UK is infecting 90 healthy young people with coronavirus. Scientists will figure out the smallest amount of virus needed to cause COVID-19. They will also study how it spreads from person to person, and which vaccine ...
Tags: Health, UK, Science, Study, Trends, Vaccine, Imperial College London, Soweto South Africa, Kwasi Kwarteng, BEIS, Samantha Lee, Coronavirus, COVID, Baragwanath Hospital, Chris Chiu, Catherine Schuster Bruce


A coronavirus variant with a mutation that 'likely helps it escape' antibodies is already in at least 11 countries, including the US

A scientist working on COVID-19 samples to find variations of the virus. Jeff Pachoud/AFP via Getty Images A new coronavirus variant has been reported in the US, the UK, and nine other countries. One of its mutations could help it escape neutralizing antibodies, one expert said. Mutations are seen as one of the biggest obstacles to ending the coronavirus pandemic. Visit the Business section of Insider for more stories. A new coronavirus variant with three mutations "of biological significa...
Tags: Health, UK, Science, Scotland, US, Trends, Getty Images, Uganda, South Africa, News UK, Brazil, Vaccines, University of Cambridge, University of Edinburgh, Afp, Irish Times


A coronavirus variant with a mutation which 'likely helps it escape' antibodies is already in at least 11 countries, including the US

A scientist works on COVID-19 samples to find variations of the virus. Jeff Pachoud/AFP via Getty Images A new variant of the coronavirus has been reported in the US, UK, and 9 other countries. One of its mutations could help it escape neutralizing antibodies, one expert said.  Mutations in the virus are one of the biggest obstacles to ending the pandemic. Visit the Business section of Insider for more stories. A new variant with three "mutations of biological significance" has been detect...
Tags: Health, UK, Science, Scotland, US, Trends, Getty Images, Uganda, South Africa, News UK, Brazil, Vaccines, University of Cambridge, University of Edinburgh, Afp, Irish Times


0 virus deaths reported from 520,000 given the Pfizer vaccine in Israel. Hardly anybody even got sick, suggesting 93% effectiveness.

An Israeli receives a coronavirus vaccine from medical staff at a COVID-19 vaccination center in Tel Aviv, Israel, Wednesday, Jan. 6, 2021. Sebastian Scheiner/AP Pfizer's vaccine is working to fight COVID-19, a leading Israeli provider firm said. Maccabi Healthcare Services said that nobody died of 520,000 people who got two doses of the shot. Israel has fully immunized 27% of its population, more than any other country.  Visit the Business section of Insider for more stories. Pfizer-BioNT...
Tags: UK, Science, Israel, Trends, South Africa, Healthcare, Pfizer, Benjamin Netanyahu, Reuters, Tel Aviv Israel, Times of Israel, Johns Hopkins University, Maccabi, Moderna, Sebastian Scheiner, Maccabi Healthcare Services


GSK and CureVac are making 'next-generation' vaccines that they say can tackle multiple COVID-19 variants at once

A healthcare worker in the Netherlands is given the Pfizer-BioNTech vaccine on January 6. Piroschka van de Wouw/Pool via AP GlaxoSmithKline and CureVac have agreed to develop new vaccines that target multiple coronavirus variants. The shots, designed as boosters in case immunity from another vaccine drops, could be available 2022. Research suggests existing vaccines may be less effective against some coronavirus variants. Visit the Business section of Insider for more stories. UK pharma gi...
Tags: Health, UK, Science, US, Trends, Research, South Africa, Healthcare, Netherlands, GlaxoSmithKline, Pfizer, GSK, CureVac, GlaxoSmithKline GSK, Moderna, AP GlaxoSmithKline


The coronavirus variant found in the UK and spreading through the US appears to be evolving a new mutation that scientists fear could help it evade vaccines

A man receives a coronavirus vaccine Michael Ciaglo/Getty Images A key mutation found in the coronavirus variants in South Africa and Brazil has now been detected in the variant found in the UK. Scientists believe the E488K mutation could help the coronavirus evade antibodies. They fear it could mean that vaccines work less well, or that people get re-infected. Visit Business Insider's homepage for more stories. The coronavirus variant first found in the UK and spreading around the world a...
Tags: Health, UK, Science, US, Trends, South Africa, Brazil, Astrazeneca, Pfizer, University of Warwick, Public Health England, Young, University of Leicester, Johnson Johnson, Tang, Novavax


What to know about 4 worrisome coronavirus variants, including one that can partially evade vaccines

A long line for general medical check-ups and COVID-19 testing forms at St. John's Well Child and Family Center in Los Angeles, California. Irfan Khan/Los Angeles Times/Getty Images There are a handful of mutated coronavirus strains worrying public health experts and vaccine developers. Some of these variants are more infectious, and may be deadlier or able to partially evade existing vaccines. Here's what to know about variants first spotted in the UK, South Africa, Brazil, and Califo...
Tags: Health, Amazon, Japan, UK, Science, London, News, Minnesota, California, Cdc, La, US, Los Angeles, Trends, Bloomberg, South Africa


Pfizer says its vaccine works against key coronavirus mutations found on the South Africa and UK variants

Vera Leip, 88, receives a Pfizer-BioNtech COVID-19 vaccine at the John Knox Village Continuing Care Retirement Community on December 16, 2020 in Pompano Beach, Florida. Joe Raedle/Getty Images In a study, Pfizer and BioNTech's vaccine worked against lab-made coronaviruses similar to variants spreading in the UK and South Africa. Small differences in how the vaccine performed against the mutations, versus the original virus, were "unlikely to lead to a significant reduction" in effectivenes...
Tags: Health, UK, Science, US, Trends, South Africa, Pfizer, Vaccine, Nih, Journal, University of Texas, National Institutes of Health NIH, Pompano Beach Florida, University of Texas at Austin, Moderna, BioNtech


Reports that AstraZeneca's vaccine is less effective in older people appear to be based on botched statistics, the German government says

82-year-old Brian Pinker receives the Oxford University/AstraZeneca COVID-19 vaccine. Steve Parsons - WPA Pool/Getty Images Media reports that AstraZeneca's COVID-19 vaccine is less effective in older people appear to be without merit. Reports in German media outlets Handelsblatt and Bild suggested the vaccine had an efficacy rate of 10% or less for those over 65. But the reports had "mixed up" the data, the German health ministry said. Visit Business Insider's homepage for more stories. R...
Tags: Health, UK, Science, Trends, Eu, Astrazeneca, University of Bristol, Vaccine, University of Oxford, Oxford University, Financial Times, Axel Springer, Reuters, Handelsblatt, Bild, European Medicines Agency


Fauci is worried that delaying second COVID-19 vaccine doses could worsen the spread of mutant virus variants

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Patrick Semansky-Pool/Getty Images Dr. Anthony Fauci said Monday that he is worried delaying the second dose of COVID-19 vaccines could "immunologically select" for virus variants. "It may not be the case, but it gets risky", Fauci said on a virtual World Economic Forum panel. He said that this is the reason the US "prefers" to keep the second dose close to the first. Other countries have delayed seco...
Tags: Health, UK, Science, Cdc, US, Trends, Bloomberg, Joe Biden, South Africa, World Health Organization, Fox News, Pfizer, Vaccine, Anthony Fauci, Centers For Disease Control And Prevention, World Economic Forum


Vaccines may not work as well against the coronavirus variant detected in South Africa, research shows. People may also face a risk of reinfection.

A volunteer receives an injection for a potential COVID-19 vaccine at the Baragwanath Hospital in Soweto, South Africa on June 28, 2020. Felix Dlangamandla/Beeld/Gallo Images via Getty Images COVID-19 vaccines may be less effective against a more infectious version of the coronavirus first found in South Africa. New research shows the mutated strain can evade the antibodies developed in response to vaccination or infection with the original version of the coronavirus. But Pfizer has said i...
Tags: Health, UK, Science, London, News, Kentucky, Trends, Cnn, South Africa, Food And Drug Administration, Pfizer, Vaccines, Seattle, Mutations, Penny, Emory University


BioNTech's CEO said there's a 'relatively high' possibility the vaccine they made with Pfizer will protect against the UK's new coronavirus variant

An Ohio State employee receives a Pfizer-BioNTech COVID-19 vaccination. AP Photo/Jay LaPrete BioNTech CEO Ugur Sahin, whose company is Pfizer's vaccine partner in Europe, told reporters on Tuesday that the "likelihood" their shot would work with regards to the UK variant was "relatively high," the Associated Press reported. Sahin noted that "we don't know at the moment if our vaccine is also able to provide protection against this new variant," and it will take up to two weeks to get da...
Tags: Europe, UK, England, Science, News, Israel, US, Trends, Ap, Healthcare, Food And Drug Administration, Fda, Associated Press, University of Bristol, Pfizer, Vaccine


6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results

A lower initial dose of the Oxford-AstraZeneca vaccine, would mean double the number of vaccine doses available, once regulators approve it. VINCENZO PINTO/AFP via Getty Images For the third consecutive Monday, a drugmaker said its coronavirus vaccine candidate was successful in late-stage studies. AstraZeneca and the University of Oxford said their two-dose shot was effective at preventing COVID-19, according to preliminary results.  AstraZeneca's news follows similar announcements of suc...
Tags: Health, UK, Science, US, Trends, Getty Images, Analysis, Healthcare, Oxford, Brazil, Astrazeneca, Pfizer, University of Oxford, Biotech, Afp, Pollard


AstraZeneca and Oxford University announced a 3rd working COVID-19 vaccine, which they say is 70% effective

Researchers said the trial of more than 20,000 volunteers showed the vaccine stopped people from developing symptoms about 70% of the time on average. Carol Smiljan/NurPhoto via Getty Images The University of Oxford and AstraZeneca released positive results for their COVID-19 vaccine on Monday. In a statement, they said the vaccine is 70% effective on average. It follows results being released for two other vaccines — developed by Pfizer and Moderna — which are 95% effective. The Oxford/As...
Tags: Europe, Japan, UK, Science, Trends, Bbc, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, European Medicines Agency, EMA, Moderna, Coronavirus, COVID-19



Filters
show more filters
January - 2021
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
25262728293031
February - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
March - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
293031